THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Lacking investors, Waltham medical firm delays its IPO

By Todd Wallack
Globe Staff / December 24, 2007

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

BG Medicine, a small Waltham company trying to develop novel medical tests, has postponed its initial public offering until next year after failing to excite enough investors to go public this month, analysts say. (Full article: 436 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass